The initial dose leading to a more Th1-dominant inflammatory response [39]—the reduced expression of ACE2 in the cilia-bearing respiratory epithelia and IL-13-dependent Th2-inflammatory mechanisms in distinct IL-13-repsonsive respiratory epithelia cells in subjects with allergies [43]—could play a role. This evidence concerns the gene ACE2 and allergic disease.